Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Cilostazol - Generic Drug Details

« Back to Dashboard

What are the generic sources for cilostazol and what is the scope of cilostazol patent protection?

Cilostazol
is the generic ingredient in two branded drugs marketed by Breckenridge Pharm, Frontida Biopharm, Sandoz, Mylan Pharms Inc, Ivax Sub Teva Pharms, Biokey, Corepharma, Mylan, West-ward Pharms Int, Teva, Actavis Elizabeth, Apotex Inc, Otsuka, and Pliva Hrvatska Doo, and is included in seventeen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cilostazol. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: cilostazol

Tradenames:2
Patents:1
Applicants:14
NDAs:17
Drug Master File Entries: see list12
Suppliers / Packagers: see list21
Bulk Api Vendors: see list80
Clinical Trials: see list29
Patent Applications: see list5,111
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cilostazol at DailyMed

Pharmacology for Ingredient: cilostazol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
CILOSTAZOL
cilostazol
TABLET;ORAL077027-001Nov 24, 2004ABRXNoYes► Subscribe► Subscribe
Biokey
CILOSTAZOL
cilostazol
TABLET;ORAL077722-001Sep 24, 2012ABRXNoNo► Subscribe► Subscribe
Frontida Biopharm
CILOSTAZOL
cilostazol
TABLET;ORAL077208-002Mar 29, 2006DISCNNoNo► Subscribe► Subscribe
Pliva Hrvatska Doo
CILOSTAZOL
cilostazol
TABLET;ORAL077898-001Oct 29, 2007DISCNNoNo► Subscribe► Subscribe
Otsuka
PLETAL
cilostazol
TABLET;ORAL020863-002Jan 15, 1999DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot